The SHOT team will host its first webinar of 2021 on 28 January, 1400–1500 GMT, and cover the Avoidable, Delayed or Under/Overtransfusion (ADU) chapter of the Annual SHOT Report 2019. Click on this story for the link to register.
Verulam Scientific Ltd is an analytical instrument company providing innovative solutions and emerging technologies to the UK pharmaceutical, environmental, life science, food, clinical and biotechnology markets. We provide laboratories with the equipment and services that are crucial to modern analytical services and research.
The diagnostic and prognostic value of plasma viscosity has been highlighted in patients suspected or confirmed as having COVID-19, but its use in other areas of UK medical practice has gained clinical acceptance over the past seven decades.
Hepatitis B, a potentially life-threatening liver infection caused by the hepatitis B virus (HBV), is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer.
28 January 2021
11-14 May 2021
3-4 November 2021
International Convention Centre, Birmingham
14-17 March 2022